Canalicular cholestasis induced by anabolic steroids

Area of Science:

• Hepatology
• Toxicology
• Endocrinology

Background:

• Anabolic-androgenic steroid (AAS) abuse is a growing public health concern, particularly among young males seeking enhanced physique or athletic performance.
• Illicit AAS use often involves unsupervised administration and non-medical purposes, increasing risks of adverse health outcomes.
• Cholestatic hepatitis is a liver injury characterized by impaired bile flow.

Observation:

• This report details a case of cholestatic hepatitis in a patient with a history of AAS use.
• The patient's presentation and laboratory findings were consistent with drug-induced liver injury.
• The temporal relationship between AAS use and the onset of liver dysfunction was noted.

Findings:

• The case confirms a direct link between anabolic steroid consumption and the development of cholestatic hepatitis.
• Histopathological examination of liver tissue supported the diagnosis of steroid-induced hepatotoxicity.
• Discontinuation of anabolic steroids led to improvement in liver function tests.

Implications:

• This case underscores the significant hepatotoxic potential of anabolic steroids when used inappropriately.
• Healthcare providers should be vigilant in screening for AAS use in patients presenting with unexplained liver abnormalities.
• Public health initiatives are needed to educate young males about the serious health risks associated with anabolic steroid abuse.